Form 4 Tracker
Patel Gautam

Director · 2 filings · Latest: Aug 10, 2026

Amneal Pharmaceuticals, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
AMRX
Patel GautamDirectorMay 7, 2026
Option Exercise
—34,819—1,643,963
AMRX
Gautam Patel—May 2, 2025
Proposed Sale
$7.74160,000$1.2M—
AMRX
Gautam J Patel—Jan 2, 2025
Proposed Sale
$8.00320,000$2.6M—